Department of Diagnostics, College of Korean Medicine, Dongguk University, Dongguk-Ro 32, Goyang 10326, Korea.
Institute of Bioscience & Integrative Medicine, Daejeon University, 75, Daedeok-daero 176, Seo-gu, Daejeon 35235, Korea.
Int J Environ Res Public Health. 2022 Oct 11;19(20):13076. doi: 10.3390/ijerph192013076.
Resembling a concealed "organ" in a holobiont, trillions of gut microbes play complex roles in the maintenance of homeostasis, including participating in drug metabolism. The conventional opinion is that most of any drug is metabolized by the host and that individual differences are principally due to host genetic factors. However, current evidence indicates that only about 60% of the individual differences in drug metabolism are attributable to host genetics. Although most common chemical drugs regulate the gut microbiota, the gut microbiota is also known to be involved in drug metabolism, like the host. Interestingly, many traditional herbal medicines and derived compounds are biotransformed by gut microbiota, manipulating the compounds' effects. Accordingly, the gut microbiota and its specified metabolic pathways can be deemed a promising target for promoting drug efficacy and safety. However, the evidence regarding causality and the corresponding mechanisms concerning gut microbiota and drug metabolism remains insufficient, especially regarding drugs used to treat metabolic disorders. Therefore, the present review aims to comprehensively summarize the bidirectional roles of gut microbiota in the effects of herbal medicine in metabolic diseases to provide vital clues for guiding the clinical application of precision medicine and personalized drug development.
类似于共生体中的隐藏“器官”,数以万亿计的肠道微生物在维持体内平衡方面发挥着复杂的作用,包括参与药物代谢。传统观点认为,大多数药物都是由宿主代谢的,个体差异主要归因于宿主的遗传因素。然而,现有证据表明,药物代谢的个体差异只有约 60%归因于宿主遗传因素。虽然大多数常见的化学药物调节肠道微生物群,但肠道微生物群也像宿主一样参与药物代谢。有趣的是,许多传统草药和衍生化合物都被肠道微生物群生物转化,从而改变化合物的作用。因此,肠道微生物群及其特定的代谢途径可以被视为提高药物疗效和安全性的有希望的靶点。然而,关于肠道微生物群与药物代谢之间因果关系及其相应机制的证据仍然不足,特别是对于用于治疗代谢紊乱的药物。因此,本综述旨在全面总结肠道微生物群在草药治疗代谢性疾病中的双向作用,为指导精准医学和个性化药物开发的临床应用提供重要线索。